Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 32

1.

Evaluation of an electronic antimicrobial time-out on antimicrobial utilization at a large health system.

Richardson SR, Neuner EA, Athans V, Srinivas P, Wesolowski J, Gordon SM, Fraser TG.

Infect Control Hosp Epidemiol. 2019 Jul;40(7):807-809. doi: 10.1017/ice.2019.105. Epub 2019 May 17.

PMID:
31099326
2.

Implementation of a Stewardship Initiative on Respiratory Viral PCR-based Antibiotic Deescalation.

Srinivas P, Rivard KR, Pallotta AM, Athans V, Martinez K, Loutzenheiser S, Lam SW, Procop GW, Richter SS, Neuner EA.

Pharmacotherapy. 2019 Jun;39(6):709-717. doi: 10.1002/phar.2268. Epub 2019 May 20.

PMID:
31049983
3.

Meropenem-Vaborbactam as Salvage Therapy for Ceftazidime-Avibactam-Resistant Klebsiella pneumoniae Bacteremia and Abscess in a Liver Transplant Recipient.

Athans V, Neuner EA, Hassouna H, Richter SS, Keller G, Castanheira M, Brizendine KD, Mathers AJ.

Antimicrob Agents Chemother. 2018 Dec 21;63(1). pii: e01551-18. doi: 10.1128/AAC.01551-18. Print 2019 Jan.

4.

Cost-effectiveness of three different strategies for the treatment of first recurrent Clostridium difficile infection diagnosed in a community setting.

Lam SW, Neuner EA, Fraser TG, Delgado D, Chalfin DB.

Infect Control Hosp Epidemiol. 2018 Aug;39(8):924-930. doi: 10.1017/ice.2018.139. Epub 2018 Jul 2.

PMID:
29961435
5.

Risk factors associated with Clostridium difficile infection in kidney transplant recipients.

Spinner ML, Stephany BR, Cerrato PM, Lam SW, Neuner EA, Patel KS.

Transpl Infect Dis. 2018 Aug;20(4):e12918. doi: 10.1111/tid.12918. Epub 2018 Jun 13.

PMID:
29797632
6.

Validation and Evaluation of Antimicrobial Orders Indication for Use.

Wang N, Neuner EA, Pallotta AM, Athans V, Wesolowski J, Willner MA, Rivard KR, Srinivas P, Fraser TG, Gordon SM.

Infect Control Hosp Epidemiol. 2018 Feb;39(2):243-245. doi: 10.1017/ice.2017.281. Epub 2018 Jan 22. No abstract available.

PMID:
29353557
7.

Evaluation of Prophylactic Antibiotic Use for Delayed Sternal Closure After Cardiothoracic Operation.

Eckardt JL, Wanek MR, Udeh CI, Neuner EA, Fraser TG, Attia T, Roselli EE.

Ann Thorac Surg. 2018 May;105(5):1365-1369. doi: 10.1016/j.athoracsur.2017.12.012. Epub 2018 Jan 12.

PMID:
29337124
8.

Evaluation of Antimicrobial Stewardship-Related Alerts Using a Clinical Decision Support System.

Ghamrawi RJ, Kantorovich A, Bauer SR, Pallotta AM, Sekeres JK, Gordon SM, Neuner EA.

Hosp Pharm. 2017 Nov;52(10):679-684. doi: 10.1177/0018578717726869. Epub 2017 Aug 29.

9.

Compliance with Procalcitonin Algorithm Antibiotic Recommendations for Patients in Medical Intensive Care Unit.

Ammar AA, Lam SW, Duggal A, Neuner EA, Bass SN, Guzman JA, Wang XF, Han X, Bauer SR.

Pharmacotherapy. 2017 Feb;37(2):177-186. doi: 10.1002/phar.1887. Epub 2017 Feb 3.

PMID:
27997675
10.

A Multifaceted Approach to Reduction of Catheter-Associated Urinary Tract Infections in the Intensive Care Unit With an Emphasis on "Stewardship of Culturing".

Mullin KM, Kovacs CS, Fatica C, Einloth C, Neuner EA, Guzman JA, Kaiser E, Menon V, Castillo L, Popovich MJ, Manno EM, Gordon SM, Fraser TG.

Infect Control Hosp Epidemiol. 2017 Feb;38(2):186-188. doi: 10.1017/ice.2016.266. Epub 2016 Nov 17.

PMID:
27852357
11.

Experience With Rapid Microarray-Based Diagnostic Technology and Antimicrobial Stewardship for Patients With Gram-Positive Bacteremia.

Neuner EA, Pallotta AM, Lam SW, Stowe D, Gordon SM, Procop GW, Richter SS.

Infect Control Hosp Epidemiol. 2016 Nov;37(11):1361-1366. Erratum in: Infect Control Hosp Epidemiol. 2017 Mar;38(3):385.

PMID:
27767002
12.

Pharmacodynamic and pharmacokinetic considerations in the treatment of critically Ill patients infected with carbapenem-resistant Enterobacteriaceae.

Neuner EA, Gallagher JC.

Virulence. 2017 May 19;8(4):440-452. doi: 10.1080/21505594.2016.1221021. Epub 2016 Aug 9. Review.

13.

Evaluation of Herpes Zoster Vaccination in HIV-Infected Patients 50 Years of Age and Older.

Bombatch C, Pallotta A, Neuner EA, Taege AJ.

Ann Pharmacother. 2016 Apr;50(4):326-7. doi: 10.1177/1060028016632262. Epub 2016 Feb 9. No abstract available.

PMID:
26861991
14.

Therapeutic drug monitoring of cerebrospinal fluid vancomycin concentration during intraventricular administration.

Popa D, Loewenstein L, Lam SW, Neuner EA, Ahrens CL, Bhimraj A.

J Hosp Infect. 2016 Feb;92(2):199-202. doi: 10.1016/j.jhin.2015.10.017. Epub 2015 Nov 6.

PMID:
26654472
15.

Influence of Colistin Dose on Global Cure in Patients with Bacteremia Due to Carbapenem-Resistant Gram-Negative Bacilli.

Gibson GA, Bauer SR, Neuner EA, Bass SN, Lam SW.

Antimicrob Agents Chemother. 2015 Nov 2;60(1):431-6. doi: 10.1128/AAC.01414-15. Print 2016 Jan.

16.

High-dose versus standard dose oseltamivir for treatment of severe influenza in adult intensive care unit patients.

Welch SC, Lam SW, Neuner EA, Bauer SR, Bass SN.

Intensive Care Med. 2015 Jul;41(7):1365-6. doi: 10.1007/s00134-015-3816-z. Epub 2015 May 8. No abstract available.

PMID:
25952823
17.

Impact of combination antimicrobial therapy on mortality risk for critically ill patients with carbapenem-resistant bacteremia.

Bass SN, Bauer SR, Neuner EA, Lam SW.

Antimicrob Agents Chemother. 2015 Jul;59(7):3748-53. doi: 10.1128/AAC.00091-15. Epub 2015 Apr 6.

18.

Compliance With Institutional Antimicrobial Dosing Guidelines in Patients Receiving Continuous Venovenous Hemodialysis.

Fedorenko M, Lam SW, Harinstein LM, Neuner EA, Demirjian S, Bauer SR.

J Pharm Pract. 2015 Aug;28(4):380-6. doi: 10.1177/0897190013519679. Epub 2014 Jan 22.

PMID:
24457540
19.

Comparison of oral vancomycin capsule and solution for treatment of initial episode of severe Clostridium difficile Infection.

Bass SN, Lam SW, Bauer SR, Neuner EA.

J Pharm Pract. 2015 Apr;28(2):183-8. doi: 10.1177/0897190013515925. Epub 2013 Dec 27.

PMID:
24375999
20.

Effect of vancomycin dose on treatment outcomes in severe Clostridium difficile infection.

Lam SW, Bass SN, Neuner EA, Bauer SR.

Int J Antimicrob Agents. 2013 Dec;42(6):553-8. doi: 10.1016/j.ijantimicag.2013.08.013. Epub 2013 Sep 21.

PMID:
24103633
21.

Comparison of treatment outcomes with vancomycin alone versus combination therapy in severe Clostridium difficile infection.

Bass SN, Bauer SR, Neuner EA, Lam SW.

J Hosp Infect. 2013 Sep;85(1):22-7. doi: 10.1016/j.jhin.2012.12.019. Epub 2013 Jul 19.

PMID:
23876778
22.

Carbapenem-resistant Enterobacteriaceae: a review of treatment and outcomes.

van Duin D, Kaye KS, Neuner EA, Bonomo RA.

Diagn Microbiol Infect Dis. 2013 Feb;75(2):115-20. doi: 10.1016/j.diagmicrobio.2012.11.009. Epub 2013 Jan 3. Review.

23.

Association between colistin dose and microbiologic outcomes in patients with multidrug-resistant gram-negative bacteremia.

Vicari G, Bauer SR, Neuner EA, Lam SW.

Clin Infect Dis. 2013 Feb;56(3):398-404. doi: 10.1093/cid/cis909. Epub 2012 Oct 22.

PMID:
23090926
24.

Experience with fosfomycin for treatment of urinary tract infections due to multidrug-resistant organisms.

Neuner EA, Sekeres J, Hall GS, van Duin D.

Antimicrob Agents Chemother. 2012 Nov;56(11):5744-8. doi: 10.1128/AAC.00402-12. Epub 2012 Aug 27.

25.

Treatment and clinical outcomes of urinary tract infections caused by KPC-producing Enterobacteriaceae in a retrospective cohort.

Alexander BT, Marschall J, Tibbetts RJ, Neuner EA, Dunne WM Jr, Ritchie DJ.

Clin Ther. 2012 Jun;34(6):1314-23. doi: 10.1016/j.clinthera.2012.05.002. Erratum in: Clin Ther. 2012 Aug;34(8):1844.

26.

Predictors of septic shock in patients with methicillin-resistant Staphylococcus aureus bacteremia.

Lam SW, Bauer SR, Neuner EA.

Int J Infect Dis. 2012 Jun;16(6):e453-6. doi: 10.1016/j.ijid.2012.02.007. Epub 2012 Apr 11.

27.

Use of therapeutic drug monitoring to treat Elizabethkingia meningoseptica meningitis and bacteraemia in an adult.

Neuner EA, Ahrens CL, Groszek JJ, Isada C, Vogelbaum MA, Fissell WH, Bhimraj A.

J Antimicrob Chemother. 2012 Jun;67(6):1558-60. doi: 10.1093/jac/dks053. Epub 2012 Feb 22. No abstract available.

28.

Implementation of a pharmacy-driven program to improve nasal mupirocin use.

Neuner EA, Sekeres J, Ristich A, Skok J, Rosenblatt M, Fatica C, Fraser TG.

Am J Health Syst Pharm. 2011 Dec 1;68(23):2222, 2224, 2226, 2228. doi: 10.2146/ajhp110021. No abstract available.

PMID:
22095809
29.

Treatment and outcomes in carbapenem-resistant Klebsiella pneumoniae bloodstream infections.

Neuner EA, Yeh JY, Hall GS, Sekeres J, Endimiani A, Bonomo RA, Shrestha NK, Fraser TG, van Duin D.

Diagn Microbiol Infect Dis. 2011 Apr;69(4):357-62. doi: 10.1016/j.diagmicrobio.2010.10.013.

30.

Extreme alkaline phosphatase elevation associated with tigecycline.

Bonilla MF, Avery RK, Rehm SJ, Neuner EA, Isada CM, van Duin D.

J Antimicrob Chemother. 2011 Apr;66(4):952-3. doi: 10.1093/jac/dkr015. Epub 2011 Feb 2. No abstract available.

PMID:
21393193
31.

Clinical, microbiologic, and genetic determinants of persistent methicillin-resistant Staphylococcus aureus bacteremia.

Neuner EA, Casabar E, Reichley R, McKinnon PS.

Diagn Microbiol Infect Dis. 2010 Jul;67(3):228-33. doi: 10.1016/j.diagmicrobio.2010.02.026.

PMID:
20542203
32.

New antibiotics for healthcare-associated pneumonia.

Neuner EA, Ritchie DJ, Micek ST.

Semin Respir Crit Care Med. 2009 Feb;30(1):92-101. doi: 10.1055/s-0028-1119813. Epub 2009 Feb 6. Review.

PMID:
19199191

Supplemental Content

Loading ...
Support Center